期刊
REGENERATIVE MEDICINE
卷 11, 期 2, 页码 181-191出版社
FUTURE MEDICINE LTD
DOI: 10.2217/rme.16.5
关键词
direct conversion; direct reprogramming; iPSC reprogramming; oligodendrocytes; transdifferentiation
资金
- National University of Singapore (NUS) [R-175-000-122-112, R-175-000-121-733, R-175-000-121-133, R-175-000-133-733]
- Maryland stem cell research fund [2013-MSCRFII-0109-00]
Rapid progress in the field of stem cell therapy and cellular reprogramming provides convincing evidence of its feasibility in treating a wide range of pathologies through autologous cell replacement therapy. This review article describes in detail on three widely used approaches of somatic cell reprogramming: induced pluripotent stem cells, direct conversion and direct reprogramming, in the context of demyelination in the CNS. The potential limitations of each reprogramming technique are reviewed along with their distinct molecular approach to reprogramming. This is followed by an analysis on the scopes and challenges of its translational applications in deriving oligodendrocyte progenitor cells and oligodendrocytes for cell replacement treatment of demyelinating conditions in the CNS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据